• Isorhamnetin in Oocyte Stress Assays

  2026-08-28

  Isorhamnetin enables mechanism-driven studies of oocyte maturation, oxidative stress, apoptosis, and endoplasmic reticulum stress. This workflow translates published 5–30 μM exposure data into practical dosing, controls, and troubleshooting decisions while preserving model-specific limitations.

• Mianserin HCl–DM-β-CD Interaction and Toxicity

  2026-08-28

  Belica-Pacha and colleagues combined calorimetry, mass spectrometry, circular dichroism, molecular docking, and cell viability testing to characterize how methylated β-cyclodextrin interacts with mianserin hydrochloride. The study shows that complexation does not necessarily reduce toxicity: MIA–DM-β-CD complexes produced lower B14-cell viability than mianserin alone, providing an important caution for formulation and cytotoxicity studies.

• Vacuolin-1: A Mechanistic Guide to Lysosomal Exocytosis

  2026-08-27

  Vacuolin-1 is a selective lysosomal exocytosis inhibitor for dissecting Ca2+-dependent lysosome–plasma membrane fusion. This guide connects disease-mechanism findings in MPS IVA with assay design, membrane repair research, and rigorous interpretation of β-hexosaminidase and Lamp-1 readouts.

• Vacuolin-1 for Lysosomal Exocytosis Assays

  2026-08-27

  Vacuolin-1 enables controlled dissection of Ca2+-dependent lysosomal exocytosis in secretion, membrane repair, and disease-model workflows. This guide connects β-hexosaminidase and Lamp-1 readouts with practical controls, optimization strategies, and findings from a mucopolysaccharidosis type IVA cartilage model.

• AP20187 for Conditional Signaling Workflows

  2026-08-26

  AP20187 converts engineered fusion protein dimerization into a controllable signal for reporter assays, regulated cell therapy, and in vivo pathway studies. This workflow also shows how a chemical inducer of dimerization can be used to test macrophage-dependent mechanisms suggested by chronic intermittent hypoxia research without confusing pathway activation with hypoxia itself.

• GPR30 in Spinal CCK+ Neurons and Neuropathic Pain

  2026-08-26

  This reference study identifies GPR30 in spinal cholecystokinin-positive neurons as a molecular and circuit-level contributor to nerve-injury-induced pain. Its combination of cell-type-specific manipulation, synaptic analysis, and S1-to-spinal-cord circuit experiments provides a framework for testing GPR30-linked mechanisms beyond generalized estrogen signaling.

• Oseltamivir Acid: From Mechanism to Translation

  2026-08-25

  A translational framework for using Oseltamivir acid in influenza antiviral research and exploratory oncology studies, integrating neuraminidase biology, resistance surveillance, assay design, prodrug metabolism, and evidence-based product selection.

• RapaLink-1 for mTOR Inhibition Workflows

  2026-08-25

  RapaLink-1 is a third-generation mTOR inhibitor built for durable pathway suppression, with practical value in resistant cancer models and emerging applications in reversible embryonic dormancy research. This guide connects mechanism to executable assay design, comparative controls, and troubleshooting without overstating evidence from mTOR inhibition studies.

• L-Phenylephrine in Sex-Aware α1A Research

  2026-08-24

  Use L-Phenylephrine to isolate α1A-linked responses across telemetry, cardiomyocyte, and neural assays. A sex-aware workflow based on conscious-mouse hypertension research improves interpretation of baroreflex, vasoconstriction, and gene-expression data.

• Vincristine Sulfate: Workflow & Troubleshooting

  2026-08-24

  Build more reproducible cancer research assays with vincristine sulfate by controlling stock preparation, exposure design, and orthogonal readouts. This workflow connects microtubule-focused phenotyping with practical troubleshooting for leukemia, lymphoma, and solid-tumor models while clearly separating evidence from optimization recommendations.

• Isoproterenol Sulfate Dihydrate in SAN Assays

  2026-08-23

  Isoproterenol sulfate dihydrate provides a defined β-adrenergic challenge for human sinoatrial node assembloids. This article explains how to use the compound to distinguish acute receptor responsiveness from neuro-cardiac maturation and structural pacemaker development.

• Matrine Workflows for Thymoma and Inflammation

  2026-08-22

  Matrine supports a practical research workflow spanning thymoma stemness, apoptosis, cancer signaling, and inflammatory injury models. This guide translates recent EL-4-B5 findings into dose planning, assay selection, controls, and troubleshooting strategies.

• MPS IVA Cartilage Pathology and Lysosomal Exocytosis

  2026-08-22

  This study identifies enhanced lysosomal exocytosis as a component of cartilage pathology in a zebrafish model of mucopolysaccharidosis type IVA (MPS IVA). Its key advance is showing that increased exocytosis does not produce the same protease and growth-factor effects in every lysosomal disease: in galns mutants, cathepsin activity and TGFβ/BMP signaling are reduced while glycosaminoglycan distribution is altered.

• Fluorinated-Sorbitol Polyplexes for mRNA Vaccine Delivery

  2026-08-21

  The reference study introduces fluorinated polyethyleneimine functionalized with sorbitol as a dual-mechanism polyplex for mRNA delivery, combining enhanced uptake with improved endosomal escape. The platform produced reporter expression in cells and mice and generated SARS-CoV-2 spike-specific immunity comparable to a Moderna LNP formulation, while leaving important formulation and translational questions for further study.

• L-Alanyl-L-Glutamine: Practical Protocol Guide

  2026-08-20

  L-Alanyl-L-Glutamine (SKU B8228) provides a stable, water-soluble L-Ala-L-Gln dipeptide for aqueous nutritional, gastrointestinal, and cell-workflow studies where glutamine delivery and solution handling must be controlled. It should be prepared in water or a validated aqueous matrix, not DMSO or ethanol, and long-term storage of prepared solutions is not recommended.

8470 records 1/565 page Next 12345 下5页 Last page